Screening strategies for discovery of antibacterial natural products

References

• Walsh CT, Antibiotics: Actions, Origin, Resistance. ASM Press, Washington, DC, USA (2003).
   Google Scholar
• Singh SB, Barrett JF. Empirical antibacterial drug discovery-foundation in natural products. Biochem. Pharmacol.71, 1006–1015 (2006).
   PubMed Web of Science ®Google Scholar
• National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infection Control.32(8), 470–485 (2004).
   PubMed Web of Science ®Google Scholar
• Talbot GH, Bradley J, Edwards JE Jr et al. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of america. Clin. Infect. Dis.42(5), 657–668 (2006).
   PubMed Web of Science ®Google Scholar
• Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis.46(2), 155–164 (2008).
   PubMed Web of Science ®Google Scholar
• Spellberg B, Blaser M, Guidos RJ et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin. Infect. Dis.52(Suppl. 5) S397–S428 (2011).
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the united states. J. Am. Med. Assoc.298(15), 1763–1771 (2007).
   PubMed Web of Science ®Google Scholar
• Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov.6(1), 29–40 (2007).
   PubMed Web of Science ®Google Scholar
• Leipe DD, Aravind L, Koonin EV. Did DNA replication evolve twice independently? Nucleic Acids Res.27(17), 3389–3401 (1999).
   PubMed Web of Science ®Google Scholar
• Pomerantz RT, O’Donnell M. Replisome mechanics: insights into a twin DNA polymerase machine. Trends Microbiol.15(4), 156–164 (2007).
   PubMed Web of Science ®Google Scholar
• Bruck I, O’Donnell M. The DNA replication machine of a Gram-positive organism. J. Biol. Chem.275(37), 28971–28983 (2000).
   PubMed Web of Science ®Google Scholar
• Mott ML, Berger JM. DNA replication initiation: mechanisms and regulation in bacteria. Nat. Rev. Microbiol.5(5), 343–354 (2007).
   PubMed Web of Science ®Google Scholar
• Darst SA. Bacterial RNA polymerase. Curr. Opin. Struct. Biol.11(2), 155–162 (2001).
   PubMed Web of Science ®Google Scholar
• Browning DF, Busby SJ. The regulation of bacterial transcription initiation. Nat. Rev. Microbiol.2(1), 57–65 (2004).
   PubMed Web of Science ®Google Scholar
• Borukhov S, Nudler E. RNA polymerase: the vehicle of transcription. Trends Microbiol.16(3), 126–134 (2008).
   PubMed Web of Science ®Google Scholar
• Akerley BJ, Rubin EJ, Novick VL et al. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc. Natl Acad. Sci. USA99(2), 966–971 (2002).
   PubMed Web of Science ®Google Scholar
• Hutchinson CA III, Peterson SN, Gill SR et al. Global transposon mutagenesis and a minimal Mycoplasma genome. Science286(5447), 2165–2169 (1999).
   PubMed Web of Science ®Google Scholar
• Ji Y, Zhang B, Van SF et al. Identification of critical Staphylococcal genes using conditional phenotypes generated by antisense RNA. Science293(5538), 2266–2269 (2001).
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Ehrlich SD, Albertini A et al. Essential Bacillus subtilis genes. Proc. Natl Acad. Sci. USA100(8), 4678–4683 (2003).
   PubMed Web of Science ®Google Scholar
• Forsyth RA, Haselbeck RJ, Ohlsen KL et al. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol. Microbiol.431387–1400 (2002).
   Google Scholar
• DeVito JA, Mills JA, Liu VG et al. An array of target-specific screening strains for antibacterial discovery. Nat. Biotechnol.20(5), 478–483 (2002).
   PubMed Web of Science ®Google Scholar
• Tashjian TF, Butler MM, Bowlin TL. Bacterial DnaA initiator protein: a novel target for developing new antibiotics. Presented at: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, USA, 17–20 September 2010.
   Google Scholar
• Mesak LR, Qi S, Villanueva I, Miao V, Davies J. Staphylococcus aureus promoter-lux reporters for drug discovery. J. Antibiot. (Tokyo)63(8), 492–498 (2010).
   PubMed Web of Science ®Google Scholar
• Ince D, Hooper DC. Quinolone resistance due to reduced target enzyme expression. J. Bacteriol.185(23), 6883–6892 (2003).
   PubMed Web of Science ®Google Scholar
• Haste NM, Perera VR, Maloney KN et al. Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus. J. Antibiot. (Tokyo)63(5), 219–224 (2010).
   PubMed Web of Science ®Google Scholar
• Li W, Leet JE, Ax HA et al. Nocathiacins, new thiazolyl peptide antibiotics from nocardia sp. I. Taxonomy, fermentation and biological activities. J. Antibiot. (Tokyo)56(3), 226–231 (2003).
   PubMed Web of Science ®Google Scholar
• Baltz RH. Antimicrobials from actinomycetes: back to the future. Microbe2(3), 125–131 (2007).
   Google Scholar
• Gadebusch HH, Stapley EO, Zimmerman SB. The discovery of cell wall active antibacterial antibiotics. Crit. Rev. Biotechnol.12(3), 225–243 (1992).
   PubMed Web of Science ®Google Scholar
• Silver LL. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? Biochem. Pharmacol.71(7), 996–1005 (2006).
   PubMed Web of Science ®Google Scholar
• Lederberg J. Bacterial protoplasts induced by penicillin. Proc. Natl Acad. Sci. USA42(9), 574–577 (1956).
   PubMed Web of Science ®Google Scholar
• Donadio S, Carrano L, Brandi L et al. Targets and assays for discovering novel antibacterial agents. J. Biotechnol.99(3), 175–185 (2002).
   PubMed Web of Science ®Google Scholar
• Schneider T, Sahl HG. An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway. Int. J. Med. Microbiol.300(2–3), 161–169 (2010).
   PubMed Web of Science ®Google Scholar
• Onishi HR, Pelak BA, Gerckens LS et al. Antibacterial agents that inhibit lipid a biosynthesis. Science274(5289), 980–982 (1996).
   PubMed Web of Science ®Google Scholar
• Billot-Klein D, Gutmann L, Collatz E, Heijenoort J. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococci. Antimicrob. Agents Chemother.36(7), 1487–1490 (1992).
   PubMed Web of Science ®Google Scholar
• Somner EA, Reynolds PE. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob. Agents Chemother.34(3), 413–419 (1990).
   PubMed Web of Science ®Google Scholar
• Ge M, Chen Z, Onishi HR et al. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-ala-D-ala. Science284(5413), 507–511 (1999).
   PubMed Web of Science ®Google Scholar
• Guan Z, Breazeale SD, Raetz CR. Extraction and identification by mass spectrometry of undecaprenyl diphosphate-murNAC-pentapeptide-glcNAC from Escherichia coli. Anal. Biochem.345(2), 336–339 (2005).
   PubMed Web of Science ®Google Scholar
• Young K, Silver LL. Leakage of periplasmic enzymes from envA1 strains of Escherichia coli. J. Bacteriol.173(12), 3609–3614 (1991).
   PubMed Web of Science ®Google Scholar
• Poole K. Multidrug resistance in Gram-negative bacteria. Curr. Opin. Microbiol.4(5), 500–508 (2001).
   PubMed Web of Science ®Google Scholar
• Markham PN, Neyfakh AA. Efflux-mediated drug resistance in Gram-positive bacteria. Curr. Opin. Microbiol.4(5), 509–514 (2001).
   PubMed Web of Science ®Google Scholar
• Young K, Jayasuriya H, Ondeyka JG et al. Discovery of FabH/FabF inhibitors from natural products. Antimicrob. Agents Chemother.50(2), 519–526 (2006).
   PubMed Web of Science ®Google Scholar
• Sugie Y, Inagaki S, Kato Y et al. CJ-21,058, a new secA inhibitor isolated from a fungus. J. Antibiot. (Tokyo)55(1), 25–29 (2002).
   PubMed Web of Science ®Google Scholar
• Wang J, Galgoci A, Kodali S et al. Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics. J. Biol. Chem.278(45), 44424–44428 (2003).
   PubMed Web of Science ®Google Scholar
• Wong KK, Kuo DW, Chabin RM et al. Engineering a cell-free murein biosynthetic pathway:  Combinatorial enzymology in drug discovery. J. Am. Chem. Soc.120(51), 13527–13528 (1998).
   Web of Science ®Google Scholar
• El Zoeiby A, Sanschagrin F, Havugimana PC, Garnier A, Levesque RC. In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa. FEMS Microbiol. Lett.201(2), 229–235 (2001).
   PubMed Web of Science ®Google Scholar
• Baum EZ, Montenegro DA, Licata L et al. Identification and characterization of new inhibitors of the Escherichia coli murA enzyme. Antimicrob. Agents Chemother.45(11), 3182–3188 (2001).
   PubMed Web of Science ®Google Scholar
• Eschenburg S, Priestman MA, Abdul-Latif FA et al. A novel inhibitor that suspends the induced fit mechanism of UDP-n-acetylglucosamine enolpyruvyl transferase (murA). J. Biol. Chem.280(14), 14070–14075 (2005).
   PubMed Web of Science ®Google Scholar
• Francisco GD, Li Z, Albright JD et al. Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis. Bioorg. Med. Chem. Lett.14(1), 235–238 (2004).
   PubMed Web of Science ®Google Scholar
• Yang Y, Severin A, Chopra R et al. 3,5-dioxopyrazolidines, novel inhibitors of UDP-n- acetylenolpyruvylglucosamine reductase (murB) with activity against Gram-positive bacteria. Antimicrob. Agents Chemother.50(2), 556–564 (2006).
   PubMed Web of Science ®Google Scholar
• Kutterer KM, Davis JM, Singh G et al. 4-Alkyl and 4,4’-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis. Bioorg. Med. Chem. Lett.15(10), 2527–2531 (2005).
   PubMed Web of Science ®Google Scholar
• Antane S, Caufield CE, Hu W et al. Pulvinones as bacterial cell wall biosynthesis inhibitors. Bioorg. Med. Chem. Lett.16(1), 176–180 (2006).
   PubMed Web of Science ®Google Scholar
• Andres CJ, Bronson JJ, D’Andrea SV et al. 4-Thiazolidinones: novel inhibitors of the bacterial enzyme murB. Bioorg. Med. Chem. Lett.10(8), 715–717 (2000).
   PubMed Web of Science ®Google Scholar
• Bronson JJ, DenBleyker KL, Falk PJ et al. Discovery of the first antibacterial small molecule inhibitors of murB. Bioorg. Med. Chem. Lett.13(5), 873–875 (2003).
   PubMed Web of Science ®Google Scholar
• Ehmann DE, Demeritt JE, Hull K, GFisher SL. Biochemical characterization of an inhibitor of Escherichia coli UDP-n-acetylmuramyl-L-alanine ligase. Biochim. Biophys. Acta.1698(2), 167–174 (2004).
   PubMed Web of Science ®Google Scholar
• Zawadzke LE, Norcia M, Desbonnet CR et al. Identification of an inhibitor of the murC enzyme, which catalyzes an essential step in the peptidoglycan precursor synthesis pathway. Assay Drug Dev. Technol.6(1), 95–103 (2008).
   PubMed Web of Science ®Google Scholar
• Kotnik M, Humljan J, Contreras-Martel C et al. Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of murD ligase. J. Mol. Biol.370(1), 107–115 (2007).
   PubMed Web of Science ®Google Scholar
• Baum EZ, Crespo-Carbone SM, Klinger A et al. A murF inhibitor that disrupts cell wall biosynthesis in Escherichia coli. Antimicrob. Agents Chemother.51(12), 4420–4426 (2007).
   PubMed Web of Science ®Google Scholar
• Brandish PE, Burnham MK, Lonsdale JT et al. Slow binding inhibition of phospho-n-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by mureidomycin A. J. Biol. Chem.271(13), 7609–7614 (1996).
   PubMed Web of Science ®Google Scholar
• Stachyra T, Dini C, Ferrari P et al. Fluorescence detection-based functional assay for high-throughput screening for mraY. Antimicrob. Agents Chemother.48(3), 897–902 (2004).
   PubMed Web of Science ®Google Scholar
• Zawadzke LE, Wu P, Cook L et al. Targeting the mraY and murG bacterial enzymes for antimicrobial therapeutic intervention. Anal. Biochem.314(2), 243–252 (2003).
   PubMed Web of Science ®Google Scholar
• Ravishankar S, Kumar VP, Chandrakala B et al. Scintillation proximity assay for inhibitors of Escherichia coli murG and, optionally, mraY. Antimicrob. Agents Chemother.49(4), 1410–1418 (2005).
   PubMed Web of Science ®Google Scholar
• Murakami R, Fujita Y, Kizuka M et al. A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. Sank 60206. J. Antibiot. (Tokyo)60(11), 690–695 (2007).
   PubMed Web of Science ®Google Scholar
• Murakami R, Fujita Y, Kizuka M et al. A-94964, A novel inhibitor of bacterial translocase I, produced by Streptomyces sp. Sank 60404. I. Taxonomy, isolation and biological activity. J. Antibiot. (Tokyo)61(9), 537–544 (2008).
   PubMed Web of Science ®Google Scholar
• Murakami R, Muramatsu Y, Minami E et al. A novel assay of bacterial peptidoglycan synthesis for natural product screening. J. Antibiot. (Tokyo)62(3), 153–158 (2009).
   PubMed Web of Science ®Google Scholar
• Wallace J, Di M, Schweizer HP, Bowlin T, LMoir DT. New cellular gain-of-signal bioluminescent reporter screens for inhibitors of the fatty acid biosynthetic pathway in pseudomonas aeruginosa. Presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA, USA, 12–15 September 2010 (Poster F2-863).
   Google Scholar
• Quillardet P, Huisman O, D’Ari R, Hofnung M. SOS chromotest, a direct assay of induction of an sos function in Escherichia coli K-12 to measure genotoxicity. Proc. Natl Acad. Sci. USA79(19), 5971–5975 (1982).
   PubMed Web of Science ®Google Scholar
• Michel B. After 30 years of study, the bacterial SOS response still surprises us. PLoS Biol.3(7), e255 (2005).
   PubMed Web of Science ®Google Scholar
• Mamber SW, Okasinski WG, Pinter CD, Tunac JB. The Escherichia coli K-12 SOS chromotest agar spot test for simple, rapid detection of genotoxic agents. Mutat. Res.171(2–3), 83–90 (1986).
   PubMed Web of Science ®Google Scholar
• Hawkey PM. Mechanisms of quinolone action and microbial response. J. Antimicrob. Chemother.51(Suppl.), 129–135 (2003).
   Google Scholar
• Majtanova L, Majtan V. Quinolone effects in the SOS chromotest and the synthesis of biomacromolecules. Folia. Microbiol. (Praha).41(3), 233–236 (1996).
   PubMed Web of Science ®Google Scholar
• Gonzalez del Val A, Platas G, Arenal F et al. Novel illudins from Coprinopsis episcopalis (syn. Coprinus episcopalis), and the distribution of illudin-like compounds among filamentous fungi. Mycol. Res.107(Pt 10), 1201–1209 (2003).
   PubMed Web of Science ®Google Scholar
• Ptitsyn LR, Horneck G, Komova O et al. A biosensor for environmental genotoxin screening based on an SOS lux assay in recombinant Escherichia coli cells. Appl. Environ. Microbiol.63(11), 4377–4384 (1997).
   PubMed Web of Science ®Google Scholar
• Kodali S, Galgoci A, Young K et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J. Biol. Chem.280(2), 1669–1677 (2005).
   PubMed Web of Science ®Google Scholar
• Sun D, Cohen S, Mani N, Murphy C, Rothstein DM. A pathway-specific cell based screening system to detect bacterial cell wall inhibitors. J. Antibiot. (Tokyo)55(3), 279–287 (2002).
   PubMed Web of Science ®Google Scholar
• Uehara T, Park JT. Role of the murein precursor UDP-N-acetylmuramyl-L-ala-γ-D-glu-meso-diaminopimelic acid-D-ala-D-ala in repression of β-lactamase induction in cell division mutants. J. Bacteriol.184(15), 4233–4239 (2002).
   PubMed Web of Science ®Google Scholar
• DeCenzo M, Kuranda M, Cohen S et al. Identification of compounds that inhibit late steps of peptidoglycan synthesis in bacteria. J. Antibiot. (Tokyo).55(3), 288–295 (2002).
   PubMed Web of Science ®Google Scholar
• Mani N, Sancheti P, Jiang ZD et al. Screening systems for detecting inhibitors of cell wall transglycosylation in Enterococcus. Cell wall transglycosylation inhibitors in Enterococcus. J. Antibiot. (Tokyo)51(5), 471–479 (1998).
   PubMed Web of Science ®Google Scholar
• Burkard M, Stein T. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis. J. Microbiol. Methods75(1), 70–74 (2008).
   PubMed Web of Science ®Google Scholar
• Hutter B, Fischer C, Jacobi A, Schaab CL, oferer H. Panel of Bacillus subtilis reporter strains indicative of various modes of action. Antimicrob. Agents Chemother.48(7), 2588–2594 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang C, Occi J, Masurekar P et al. Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347. J. Am. Chem. Soc.130(36), 12102–12110 (2008).
   PubMed Web of Science ®Google Scholar
• Allen GC Jr, Kornberg A. Fine balance in the regulation of dnaB helicase by dnaC protein in replication in Escherichia coli. J. Biol. Chem.266(33), 22096–22101 (1991).
   PubMed Web of Science ®Google Scholar
• Kaguni JM. DnaA: controlling the initiation of bacterial DNA replication and more. Annu. Rev. Microbiol.60, 351–375 (2006).
   PubMed Web of Science ®Google Scholar
• Studier FW, Moffatt BA. Use of bacteriophage t7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol.189(1), 113–130 (1986).
   PubMed Web of Science ®Google Scholar
• Studier FW. Use of bacteriophage t7 lysozyme to improve an inducible t7 expression system. J. Mol. Biol.219(1), 37–44 (1991).
   PubMed Web of Science ®Google Scholar
• Fossum S, De Pascale G, Weigel C et al. A robust screen for novel antibiotics: specific knockout of the initiator of bacterial DNA replication. FEMS Microbiol. Lett.281(2), 210–214 (2008).
   PubMed Web of Science ®Google Scholar
• Uchida K, Furukohri A, Shinozaki Y et al. Overproduction of Escherichia coli DNA polymerase dinB (pol iv) inhibits replication fork progression and is lethal. Mol. Microbiol.70(3), 608–622 (2008).
   PubMed Web of Science ®Google Scholar
• Hammond GG, Cassidy PJ, Overbye KM. Novobiocin-dependent topA deletion mutants of Escherichia coli. J. Bacteriol.173(17), 5564–5567 (1991).
   PubMed Web of Science ®Google Scholar
• Ji Y, Marra A, Rosenberg M, Woodnutt G. Regulated antisense RNA eliminates α-toxin virulence in Staphylococcus aureus infection. J. Bacteriol.181(21), 6585–6590 (1999).
   PubMed Web of Science ®Google Scholar
• Singh SB, Phillips JW, Wang J. Highly sensitive target based whole cell antibacterial discovery strategy by antisense RNA silencing. Curr. Opin. Drug Disc. Dev.10, 160–166 (2007).
   PubMedGoogle Scholar
• Donald RG, Skwish S, Forsyth RA et al. A Staphylococcus aureus Fitness Test platform for mechanism-based profiling of antibacterial compounds. Chem. Biol.16(8), 826–836 (2009).
   PubMed Web of Science ®Google Scholar
• Goetz MA, Zhang C, Zink DL et al. Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus Fitness Test profiling. J. Antibiot. (Tokyo).63(8), 512–518 (2010).
   PubMed Web of Science ®Google Scholar
• Huber J, Donald RG, Lee SH et al. Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus. Chem. Biol.16(8), 837–848 (2009).
   PubMed Web of Science ®Google Scholar
• Finn RD, Tate J, Mistry J et al. The pfam protein families database. Nucleic Acids Research.36(Suppl. 1), D281–D288 (2008).
   PubMed Web of Science ®Google Scholar
• Inoue A, Murata Y, Takahashi H et al. Involvement of an essential gene, mviN, in murein synthesis in Escherichia coli. J. Bacteriol.190(21), 7298–7301 (2008).
   PubMed Web of Science ®Google Scholar
• Ruiz N. Bioinformatics identification of murJ. (mviN) as the peptidoglycan lipid II flippase in Escherichia coli. Proc. Natl Acad. Sci. USA105(40), 15553–15557 (2008).
   PubMed Web of Science ®Google Scholar
• Ruiz N. Streptococcus pyogenes ytgP (spy_0390) complements Escherichia coli strains depleted of the putative peptidoglycan flippase murj. Antimicrob. Agents Chemother.53(8), 3604–3605 (2009).
   PubMed Web of Science ®Google Scholar
• Kulanthaivel P, Kreuzman AJ, Strege MA et al. Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I. J. Biol. Chem.279(35), 36250–36258 (2004).
   PubMed Web of Science ®Google Scholar
• Paetzel M, Goodall JJ, Kania M, Dalbey RE, Page MG. Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor. J. Biol. Chem.279(29), 30781–30790 (2004).
   PubMed Web of Science ®Google Scholar
• Mansour TS, Caufield CE, Rasmussen B et al. Naphthyl tetronic acids as multi-target inhibitors of bacterial peptidoglycan biosynthesis. ChemMedChem2(10), 1414–1417 (2007).
   PubMed Web of Science ®Google Scholar
• McDonald LA, Barbieri LR, Carter GT et al. Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors. J. Am. Chem. Soc.124(35), 10260–10261 (2002).
   PubMed Web of Science ®Google Scholar
• Fujita Y, Murakami R, Muramatsu Y, Miyakoshi S, Takatsu T. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. Sank 60404. II. Physico-chemical properties and structure elucidation. J. Antibiot. (Tokyo)61(9), 545–549 (2008).
   PubMed Web of Science ®Google Scholar
• Brinster S, Lamberet G, Staels B et al. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature458(7234), 83–86 (2009).
   PubMed Web of Science ®Google Scholar
• Wang J, Soisson SM, Young K et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature441, 358–361 (2006).
   PubMed Web of Science ®Google Scholar
• Rapp C, Jung G, Isselhorst-Schart C, Zahner H. A new member of the class of antibiotics with thiotetromic acid structure isolated from Streptomyces olivaceus Tü3010. Liebigs Ann. Chem.1043–1047 (1988).
   Google Scholar
• Ondeyka JG, Zink DL, Young K et al. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense based strategy. J. Nat. Prod.69, 377–380 (2006).
   PubMed Web of Science ®Google Scholar
• Singh SB, Jayasuriya H, Ondeyka JG et al. Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. J. Am. Chem. Soc.128(36), 11916–11920 (2006).
   PubMed Web of Science ®Google Scholar
• Wang J, Kodali S, Lee SH et al. Platencin is a dual FabF and FabH inhibitor with potent in vivo antibiotic properties. Proc. Natl Acad. Sci. USA104, 7612–7616 (2007).
   PubMed Web of Science ®Google Scholar
• Jayasuriya H, Herath KB, Zhang C et al. Isolation and structure of platencin: a novel FabH and FabF dual inhibitor with potent broad spectrum antibiotic activity produced by Streptomyces platensis MA7339. Angew. Chem. Int. Ed. Engl.46, 4684–4688 (2007).
   PubMed Web of Science ®Google Scholar
• Singh MP, Kong F, Janso J. E et al. Novel α-pyrones produced by a marine Pseudomonas sp. F92s91: taxonomy and biological activities. J. Antibiot. (Tokyo)56(12), 1033–1044 (2003).
   PubMed Web of Science ®Google Scholar
• Kong F, Singh MP, Carter GT. Pseudopyronines A and B, α-pyrones produced by a marine Pseudomonas sp. F92s91, and evidence for the conversion of 4-hydroxy-α-pyrone to 3-furanone. J. Nat. Prod.68(6), 920–923 (2005).
   PubMed Web of Science ®Google Scholar
• Constantine KL, Mueller L, Huang S et al. Conformation and absolute configuration of nocathiacin I determined by NMR spectroscopy and chiral capillary electrophoresis. J. Am. Chem. Soc.124(25), 7284–7285 (2002).
   PubMed Web of Science ®Google Scholar
• Singh SB, Occi J, Jayasuriya H et al. Antibacterial evaluations of thiazomycin – a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J. Antibiot. (Tokyo)60(9), 565–571 (2007).
   PubMed Web of Science ®Google Scholar
• Jayasuriya H, Herath K, Ondeyka JG et al. Isolation and structure elucidation of thiazomycin – a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J. Antibiot. (Tokyo)60(9), 554–564 (2007).
   PubMed Web of Science ®Google Scholar
• Poehlsgaard J, Douthwaite S. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol.3, 870–881 (2005).
   PubMed Web of Science ®Google Scholar
• Ramakrishnan V. Ribosome structure and the mechanism of translation. Cell108(4), 557–572 (2002).
   PubMed Web of Science ®Google Scholar
• Culver GM. Assembly of the 30s ribosomal subunit. Biopolymers68, 234–249 (2003).
   PubMed Web of Science ®Google Scholar
• Ogle JM, Carter AP, Ramakrishnan V. Insights into the decoding mechanism from recent ribosome structures. Trends Biochem. Sci.28(5), 259–266 (2003).
   PubMed Web of Science ®Google Scholar
• Grundy FJ, Henkin TM. The rpsd gene, encoding ribosomal protein s4, is autogenously regulated in Bacillus subtilis. J. Bacteriol.173(15), 4595–4602 (1991).
   PubMed Web of Science ®Google Scholar
• Singh SB, Zink DL, Huber J et al. Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy. Org. Lett.8(24), 5449–5452 (2006).
   PubMed Web of Science ®Google Scholar
• Singh SB, Zink DL, Herath KB, Salazar O, Genilloud O. Discovery and antibacterial activity of lucensimycin C from Streptomyces lucensis. Tetrahedron Lett.49(16), 2616–2619 (2008).
   Web of Science ®Google Scholar
• Singh SB, Zink DL, Dorso K et al. Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy. J. Nat. Prod.72, 345–352 (2008).
   Web of Science ®Google Scholar
• Zhang C, Ondeyka JG, Zink DL et al. Isolation, structure and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. Discovered by antisense strategy. J. Nat. Prod.71, 1304–1307 (2008).
   PubMed Web of Science ®Google Scholar
• Ondeyka JG, Zink D, Basilio A et al. Coniothyrione, a chlorocyclopentandienylbenzopyrone as a bacterial protein synthesis inhibitor discovered by antisense technology. J. Nat. Prod.70(4), 668–670 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang C, Ondeyka JG, Zink DL et al. Isolation, structure and antibacterial activity of pleosporone from a Pleosporalean ascomycete discovered by using antisense strategy. Bioorg. Med. Chem.17(6), 2162–2166 (2009).
   PubMed Web of Science ®Google Scholar
• Jayasuriya H, Zink D, Basilio A et al. Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy. J. Antibiot. (Tokyo)62(5), 265–269 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang C, Ondeyka JG, Zink DL et al. Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein s4. J. Antibiot. (Tokyo)62(2), 55–61 (2009).
   PubMed Web of Science ®Google Scholar
• Riedlinger J, Reicke A, Zahner H et al. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. (Tokyo)57(4), 271–279 (2004).
   PubMed Web of Science ®Google Scholar
• Bister B, Bischoff D, Strobele M et al. Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew. Chem. Int. Ed. Engl.43(19), 2574–2576 (2004).
   PubMed Web of Science ®Google Scholar
• Goetschi E, Angehrn P, Gmuender H et al. Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors. Pharmacol. Ther.60(2), 367–380 (1993).
   PubMed Web of Science ®Google Scholar
• Nakada N, Shimada H, Hirata T et al. Biological characterization of cyclothialidine, a new DNA gyrase inhibitor. Antimicrob. Agents Chemother.37(12), 2656–2661 (1993).
   PubMed Web of Science ®Google Scholar
• Mariani R, Granata G, Maffioli SI et al. Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: chemical derivatization. Bioorg. Med. Chem. Lett.15(16), 3748–3752 (2005).
   PubMed Web of Science ®Google Scholar
• Ciciliato I, Corti E, Sarubbi E et al. Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization. J. Antibiot. (Tokyo)57(3), 210–217 (2004).
   PubMed Web of Science ®Google Scholar
• Sarubbi E, Monti F, Corti E, Miele A, Selva E. Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase. Eur. J. Biochem.271(15), 3146–3154 (2004).
   PubMedGoogle Scholar
• Villain-Guillot P, Bastide L, Gualtieri M, Leonetti JP. Progress in targeting bacterial transcription. Drug Discov. Today12(5–6), 200–208 (2007).
   PubMed Web of Science ®Google Scholar
• Theriault RJ, Karwowski JP, Jackson M et al. Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity. J. Antibiot. (Tokyo)40(5), 567–574 (1987).
   PubMed Web of Science ®Google Scholar
• Gerber M, Ackermann G. Opt-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review. Expert Opin. Investig. Drugs17(4), 547–553 (2008).
   PubMed Web of Science ®Google Scholar
• Parenti F, Pagani H, Beretta G. Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies. J. Antibiot. (Tokyo)28(4), 247–252 (1975).
   PubMed Web of Science ®Google Scholar
• Talpaert M, Campagnari F, Clerici L. Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases. Biochem. Biophys. Res. Commun.63(1), 328–334 (1975).
   PubMed Web of Science ®Google Scholar
• Kurabachew M, Lu SH, Krastel P et al. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. J. Antimicrob. Chemother.62(4), 713–719 (2008).
   PubMed Web of Science ®Google Scholar
• Gualtieri M, Villain-Guillot P, Latouche J, Leonetti JP, Bastide L. Mutation in the Bacillus subtilis RNA polymerase β’ subunit confers resistance to lipiarmycin. Antimicrob. Agents Chemother.50(1), 401–402 (2006).
   PubMed Web of Science ®Google Scholar
• Irschik H, Gerth K, Hofle G, Kohl W, Reichenbach H. The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (myxobacterales). J. Antibiot. (Tokyo)36(12), 1651–1658 (1983).
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay J, Das K, Ismail S et al. The RNA polymerase “switch region” is a target for inhibitors. Cell135(2), 295–307 (2008).
   PubMed Web of Science ®Google Scholar
• Chu M, Mierzwa R, He L et al. Isolation and structure elucidation of two novel deformylase inhibitors produced by Streptomyces sp. Tetrahedron Lett.42(21), 3549–3551 (2001).
   Web of Science ®Google Scholar
• Koyama N, Nagahiro T, Yamaguchi Y et al. Stemphones, novel potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Aspergillus sp. FKI-2136. J. Antibiot. (Tokyo)58(11), 695–703 (2005).
   PubMed Web of Science ®Google Scholar
• Fukumoto A, Kim YP, Hanaki H et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04–0144. II. Biological activities. J. Antibiot. (Tokyo)61(1), 7–10 (2008).
   PubMed Web of Science ®Google Scholar
• Fukumoto A, Kim YP, Matsumoto A et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04–0144. I. Taxonomy, fermentation, isolation and structural elucidation. J. Antibiot. (Tokyo)61(1), 1–6 (2008).
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Omura S, Tomoda H, Xanthoradone C, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765–3762. J. Antibiot. (Tokyo)63(6), 329–330 (2010).
   PubMed Web of Science ®Google Scholar
• Hughes CC, Prieto-Davo A, Jensen PR, Fenical W. The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org. Lett.10(4), 629–631 (2008).
   PubMed Web of Science ®Google Scholar
• Parish CA, de la Cruz M, Smith SK et al. Antisense-guided isolation and structure elucidation of pannomycin, a substituted cis-decalin from Geomyces pannorum. J. Nat. Prod.72(1), 59–62 (2009).
   PubMed Web of Science ®Google Scholar
• Parish CA, Huber J, Baxter J et al. A new ene-triyne antibiotic from the fungus Baeospora myosura. J. Nat. Prod.67(11), 1900–1902 (2004).
   PubMed Web of Science ®Google Scholar